Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Ring X and other structural X chromosome abnormalities: X inactivation and phenotype.

Identifieur interne : 009976 ( Main/Exploration ); précédent : 009975; suivant : 009977

Ring X and other structural X chromosome abnormalities: X inactivation and phenotype.

Auteurs : K A Leppig [États-Unis] ; C M Disteche

Source :

RBID : pubmed:11480912

Descripteurs français

English descriptors

Abstract

Patients who carry a structural abnormality of the X chromosome are a fascinating group who have provided opportunities to evaluate genotype/phenotype correlation in relation to X chromosome content and inactivation. Turner syndrome (TS) is most commonly associated with a 45,X karyotype and presents with an array of phenotypes, the main ones being poor viability in utero, ovarian failure and infertility, short stature, lymphedema, and other congenital malformations but usually not mental retardation. In some TS patients the karyotype shows both a normal X and a structurally rearranged X chromosome. These structural abnormalities, which include deletions, duplications, inversions, translocations, and rings, are associated with chromosome breaks and significant imbalance of gene content of the X chromosome. However, such abnormalities are generally well tolerated because of the preferential inactivation of the abnormal X, which can restore, at least in part, a balanced genetic makeup. This beneficial effect of X inactivation results in a mild phenotype in most patients with structural abnormalities of the X, similar to that found in TS patients with a 45,X karyotype. However, in cases of ring X chromosomes and of X/autosome translocations the incidence of mental retardation and other congenital abnormalities can be significantly higher than in TS. These abnormal phenotypes can be ascribed to failed or partial X inactivation and/or incomplete selection in favor of cells with normal balance of gene expression. In this article, we present phenotype/genotype correlation in female patients with structural abnormalities of the X and address the role of X inactivation and cell selection in the phenotypic findings. Our review emphasizes a subset of rare patients with ring X chromosomes who have provided evidence of a direct role for X inactivation in determining phenotypes.

DOI: 10.1055/s-2001-15395
PubMed: 11480912


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Ring X and other structural X chromosome abnormalities: X inactivation and phenotype.</title>
<author>
<name sortKey="Leppig, K A" sort="Leppig, K A" uniqKey="Leppig K" first="K A" last="Leppig">K A Leppig</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pediatrics, University of Washington, Seattle 98195-7470, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, University of Washington, Seattle 98195-7470</wicri:regionArea>
<orgName type="university">Université de Washington</orgName>
<placeName>
<settlement type="city">Seattle</settlement>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Disteche, C M" sort="Disteche, C M" uniqKey="Disteche C" first="C M" last="Disteche">C M Disteche</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11480912</idno>
<idno type="pmid">11480912</idno>
<idno type="doi">10.1055/s-2001-15395</idno>
<idno type="wicri:Area/PubMed/Corpus">004772</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004772</idno>
<idno type="wicri:Area/PubMed/Curation">004772</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004772</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004772</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004772</idno>
<idno type="wicri:Area/Ncbi/Merge">000714</idno>
<idno type="wicri:Area/Ncbi/Curation">000714</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000714</idno>
<idno type="wicri:doubleKey">1526-8004:2001:Leppig K:ring:x:and</idno>
<idno type="wicri:Area/Main/Merge">009D83</idno>
<idno type="wicri:Area/Main/Curation">009976</idno>
<idno type="wicri:Area/Main/Exploration">009976</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Ring X and other structural X chromosome abnormalities: X inactivation and phenotype.</title>
<author>
<name sortKey="Leppig, K A" sort="Leppig, K A" uniqKey="Leppig K" first="K A" last="Leppig">K A Leppig</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pediatrics, University of Washington, Seattle 98195-7470, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pediatrics, University of Washington, Seattle 98195-7470</wicri:regionArea>
<orgName type="university">Université de Washington</orgName>
<placeName>
<settlement type="city">Seattle</settlement>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Disteche, C M" sort="Disteche, C M" uniqKey="Disteche C" first="C M" last="Disteche">C M Disteche</name>
</author>
</analytic>
<series>
<title level="j">Seminars in reproductive medicine</title>
<idno type="ISSN">1526-8004</idno>
<imprint>
<date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Chromosome Deletion</term>
<term>Chromosome Inversion</term>
<term>Dosage Compensation, Genetic</term>
<term>Female</term>
<term>Gene Duplication</term>
<term>Humans</term>
<term>Phenotype</term>
<term>RNA, Long Noncoding</term>
<term>RNA, Untranslated (genetics)</term>
<term>Ring Chromosomes</term>
<term>Sex Chromosome Aberrations</term>
<term>Transcription Factors (genetics)</term>
<term>Translocation, Genetic (genetics)</term>
<term>Turner Syndrome (genetics)</term>
<term>X Chromosome (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN long non codant</term>
<term>ARN non traduit (génétique)</term>
<term>Aberrations des chromosomes sexuels</term>
<term>Chromosome X (génétique)</term>
<term>Chromosomes en anneau</term>
<term>Compensation de dosage génétique</term>
<term>Duplication de gène</term>
<term>Délétion de segment de chromosome</term>
<term>Facteurs de transcription (génétique)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inversion chromosomique</term>
<term>Phénotype</term>
<term>Syndrome de Turner (génétique)</term>
<term>Translocation génétique (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>RNA, Untranslated</term>
<term>Transcription Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>RNA, Long Noncoding</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Translocation, Genetic</term>
<term>Turner Syndrome</term>
<term>X Chromosome</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>ARN non traduit</term>
<term>Chromosome X</term>
<term>Facteurs de transcription</term>
<term>Syndrome de Turner</term>
<term>Translocation génétique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Chromosome Deletion</term>
<term>Chromosome Inversion</term>
<term>Dosage Compensation, Genetic</term>
<term>Female</term>
<term>Gene Duplication</term>
<term>Humans</term>
<term>Phenotype</term>
<term>Ring Chromosomes</term>
<term>Sex Chromosome Aberrations</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>ARN long non codant</term>
<term>Aberrations des chromosomes sexuels</term>
<term>Chromosomes en anneau</term>
<term>Compensation de dosage génétique</term>
<term>Duplication de gène</term>
<term>Délétion de segment de chromosome</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inversion chromosomique</term>
<term>Phénotype</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Patients who carry a structural abnormality of the X chromosome are a fascinating group who have provided opportunities to evaluate genotype/phenotype correlation in relation to X chromosome content and inactivation. Turner syndrome (TS) is most commonly associated with a 45,X karyotype and presents with an array of phenotypes, the main ones being poor viability in utero, ovarian failure and infertility, short stature, lymphedema, and other congenital malformations but usually not mental retardation. In some TS patients the karyotype shows both a normal X and a structurally rearranged X chromosome. These structural abnormalities, which include deletions, duplications, inversions, translocations, and rings, are associated with chromosome breaks and significant imbalance of gene content of the X chromosome. However, such abnormalities are generally well tolerated because of the preferential inactivation of the abnormal X, which can restore, at least in part, a balanced genetic makeup. This beneficial effect of X inactivation results in a mild phenotype in most patients with structural abnormalities of the X, similar to that found in TS patients with a 45,X karyotype. However, in cases of ring X chromosomes and of X/autosome translocations the incidence of mental retardation and other congenital abnormalities can be significantly higher than in TS. These abnormal phenotypes can be ascribed to failed or partial X inactivation and/or incomplete selection in favor of cells with normal balance of gene expression. In this article, we present phenotype/genotype correlation in female patients with structural abnormalities of the X and address the role of X inactivation and cell selection in the phenotypic findings. Our review emphasizes a subset of rare patients with ring X chromosomes who have provided evidence of a direct role for X inactivation in determining phenotypes.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Washington (État)</li>
</region>
<settlement>
<li>Seattle</li>
</settlement>
<orgName>
<li>Université de Washington</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Disteche, C M" sort="Disteche, C M" uniqKey="Disteche C" first="C M" last="Disteche">C M Disteche</name>
</noCountry>
<country name="États-Unis">
<region name="Washington (État)">
<name sortKey="Leppig, K A" sort="Leppig, K A" uniqKey="Leppig K" first="K A" last="Leppig">K A Leppig</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009976 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009976 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:11480912
   |texte=   Ring X and other structural X chromosome abnormalities: X inactivation and phenotype.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:11480912" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024